Edap Tms S.A. (NASDAQ:EDAP - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.24 and traded as high as $8.30. Edap Tms shares last traded at $7.84, with a volume of 34,840 shares changing hands.
Analyst Ratings Changes
EDAP has been the topic of a number of recent research reports. StockNews.com raised shares of Edap Tms from a "sell" rating to a "hold" rating in a report on Thursday. HC Wainwright lifted their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the company a "buy" rating in a research report on Monday, April 1st.
Check Out Our Latest Stock Report on Edap Tms
Edap Tms Stock Down 3.4 %
The company has a current ratio of 2.84, a quick ratio of 2.30 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $279.41 million, a price-to-earnings ratio of -12.02 and a beta of 0.74. The firm's 50 day simple moving average is $7.03 and its 200-day simple moving average is $6.25.
Hedge Funds Weigh In On Edap Tms
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Milestone Investment Advisors LLC acquired a new stake in Edap Tms in the 3rd quarter valued at about $39,000. Rock Springs Capital Management LP lifted its holdings in Edap Tms by 14.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider's stock valued at $9,547,000 after purchasing an additional 173,700 shares in the last quarter. Summit Trail Advisors LLC purchased a new position in Edap Tms in the 3rd quarter valued at about $77,000. JPMorgan Chase & Co. lifted its holdings in Edap Tms by 80.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,943 shares of the medical equipment provider's stock valued at $102,000 after purchasing an additional 6,654 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in Edap Tms in the 2nd quarter valued at about $86,000. 62.74% of the stock is owned by institutional investors and hedge funds.
About Edap Tms
(
Get Free Report)
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).
See Also
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
